2192
vs
H
Hang Seng (Hong Kong)
2192
Over the past 12 months, Medlive Technology Co Ltd has underperformed Hang Seng (Hong Kong), delivering a return of -27% compared to the Hang Seng (Hong Kong)'s +11% growth.
Stocks Performance
2192 vs Hang Seng (Hong Kong)
Performance Gap
2192 vs Hang Seng (Hong Kong)
Performance By Year
2192 vs Hang Seng (Hong Kong)
Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.
Medlive Technology Co Ltd
Glance View
Medlive Technology Co., Ltd. operates as an investment holding company. The company is headquartered in Beijing, Beijing. The company went IPO on 2021-07-15. The firm mainly operates three segments. Its Precision Marketing and Corporate Solutions segment provides precision marketing solutions and corporate solutions. Its precision marketing solutions include digital detailing, digital marketing consulting and digital content creation services. Its revenue of its corporate solutions is primarily software as a service (SaaS). The Medical Knowledge Solutions segment mainly provides professional medical information and medical software services. The Intelligent Patient Management Solutions segment mainly provides online patient consultation and prescription services and patient management services. The firm mainly conducts its business within domestic market.
